Slippery Elm

Metadata

Approved Indications

Commission E (Germany)

• No Commission E monograph exists for slippery elm
• Reason: Ulmus rubra is a North American species without a tradition of use in European phytotherapy; it was not part of the Commission E review scope

ESCOP

• No ESCOP monograph has been published for slippery elm

EMA/HMPC (European Medicines Agency)

• No EMA/HMPC monograph exists for Ulmus rubra
• Reason: The plant is not used in traditional European herbal medicine; EMA monographs cover herbs with documented European use

FDA (United States)

• OTC Demulcent: The FDA classifies slippery elm bark as a “safe and effective” OTC oral demulcent (21 CFR 346.14)
• This is one of the few cases where the FDA has explicitly recognized an herbal substance as both safe and effective for a specific indication
• The approved use is for temporary relief of minor pain and protection of irritated areas of the mouth and throat

US Pharmacopeia (USP)

• Slippery elm bark was included in the United States Pharmacopeia from 1820 through the 20th century
• Historical USP listing reflects the longstanding recognition of its medicinal use in American herbal tradition

Agreement/Disagreement Between Bodies

• Transatlantic gap: The complete absence of European monographs reflects geography and tradition, not a negative evaluation of efficacy
• FDA recognition: The FDA OTC demulcent classification provides stronger regulatory recognition than many herbs receive; it explicitly states “safe and effective” rather than merely “GRAS”
• Evidence paradox: FDA approved this herb based on traditional use and pharmacological plausibility before the modern clinical trial era; it has retained approval despite the absence of RCTs

Conditions Treated

Primary (Traditional Use with Pharmacological Plausibility)

• Sore throat and pharyngeal irritation: Demulcent coating of irritated throat mucosa; supported by FDA OTC classification and widespread use in throat lozenges
• Gastroesophageal reflux (GERD) / heartburn: Mucilage forms a protective barrier over inflamed esophageal mucosa; traditional use is strong but clinical trial evidence is absent for monotherapy

Secondary (Traditional Use)

• Irritable bowel syndrome (IBS): Traditional use as a soothing agent for irritated bowel mucosa; one clinical study of a multi-ingredient formula (NC Gut Relief Formula containing slippery elm) showed improved IBS symptoms, but the individual contribution of slippery elm cannot be isolated
• Gastritis and peptic ulcer: Demulcent coating of gastric mucosa; traditional rationale is sound but unstudied clinically
• Inflammatory bowel disease (Crohn’s, ulcerative colitis): Used by patients as a complementary therapy; no clinical evidence

Traditional/Historical (No Clinical Evidence)

• Cough and bronchial irritation (demulcent for respiratory mucosa)
• Urinary tract inflammation (traditional Native American use)
• Topical wound healing (poultice of bark)
• Diarrhea (astringent tannin content)
• Constipation (bulk-forming mucilage)
• Nutritive gruel for convalescents (historical use as food for the sick)

Mechanism of Action

Primary Mechanisms

Demulcent/mucoprotective:

• The inner bark mucilage is a complex polysaccharide that absorbs water and swells to form a viscous gel
• When ingested, this gel coats and adheres to the mucous membranes of the oropharynx, esophagus, and stomach
• The coating provides a physical barrier that protects irritated tissue from further mechanical or chemical irritation (including gastric acid in GERD)
• Stimulates reflex secretion of mucus by the mucosal glands, enhancing the protective mucus layer (the “demulcent reflex” described in traditional pharmacology)

Sialagogue / mucus-stimulating:

• Slippery elm stimulates saliva production and mucus secretion in the throat and upper GI tract
• Increased saliva acts as a natural antacid (salivary bicarbonate) and further protects the esophagus

Secondary Mechanisms

Comparison with Other Demulcents

• Slippery elm mucilage is functionally similar to marshmallow root (Althaea officinalis) mucilage; both form protective coatings over mucous membranes
• Unlike synthetic antacids or proton pump inhibitors, slippery elm does not alter gastric acid production; it provides purely physical protection
• The bulk-forming mucilage shares properties with psyllium husk and linseed, though slippery elm is used primarily for upper GI rather than lower GI conditions

Clinical Evidence Summary

Volume of Evidence

• Extremely limited. No published RCTs evaluate slippery elm as a monotherapy for any condition. The pharmacological rationale is clear (mucilage content and demulcent properties are well-characterized), but clinical validation through modern trials is essentially absent.

Key Studies

IBS (Multi-Ingredient Formula)

Laryngeal Irritation

Evidence Gaps

• No RCTs for slippery elm monotherapy in any condition
• No dose-response studies
• No head-to-head comparisons with marshmallow root or synthetic demulcents
• No modern pharmacokinetic data (mucilage is not systemically absorbed, so traditional PK studies are not directly applicable; however, mucosal residence time and coating effectiveness have not been formally measured)
• No long-term safety data from controlled studies
• The mucilage composition has been characterized, but the specific polysaccharide structures responsible for demulcent activity have not been fully elucidated
• No studies compare different slippery elm preparations (powder, tea, lozenge) for efficacy

European vs US/Anglophone Consensus

Safety Profile

Contraindications

• Known hypersensitivity to slippery elm or other Ulmaceae species
• No absolute contraindications are established

Drug Interactions

• Absorption interference: The mucilage may slow or reduce the absorption of orally administered medications if taken simultaneously. This is a class effect of demulcent/mucilaginous substances, not specific to slippery elm
• Recommendation: Take slippery elm at least 2 hours before or after any oral medications to avoid potential absorption interference
• No specific drug-herb interactions have been documented in clinical reports

Side Effects

• Generally recognized as safe (FDA OTC status)
• No significant adverse effects reported in the literature
• Allergic reactions are possible but not documented in the literature
• Contact dermatitis from handling raw bark has been reported rarely

Pregnancy/Lactation

• Pregnancy: Safety data is lacking for medicinal use during pregnancy. Some traditional sources caution against use in pregnancy (concern about potential abortifacient effects of whole bark, though the inner bark mucilage itself is not known to have this property). Conservative recommendation: avoid in pregnancy or use only under professional supervision
• Lactation: Insufficient data; likely safe given the non-systemic nature of the mucilage, but formal safety data is absent
• Children: Not specifically studied; traditional use in children exists (as a soothing agent for sore throat); the EMA recommends that herbs without specific safety data not be used in children under 18

Clinical Dosage

Standard Dosage Forms

Key Dosing Notes

• Preparation matters: Whole powdered bark mixed directly in water produces the most effective mucilage gel; alcohol-based extracts may partially denature the mucilage polysaccharides
• Timing: Take 15-30 minutes before meals for GERD/heartburn, or as needed for sore throat
• Drug separation: Allow at least 2 hours between slippery elm and any oral medications to avoid absorption interference
• Water: Always take with adequate water; the mucilage requires hydration to function
• Duration: Can be used long-term for chronic conditions; no safety concerns have emerged from traditional use, though formal long-term study data is absent
• Quality considerations: Source from reputable suppliers to ensure the inner bark (not outer bark) is used; sustainable harvesting is an ethical consideration given Dutch elm disease impacts

Sources

• LiverTox. Slippery Elm. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). ncbi.nlm.nih.gov/books/NBK599741
• Watts CR, et al. Slippery elm, its biochemistry, and use as a complementary and alternative treatment for laryngeal irritation. Am J Physiol Biochem Pharmacol. 2012;1(1):1-7
• Hawrelak JA, Myers SP. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study. J Altern Complement Med. 2010;16(10):1065-1071
• Langmead L, et al. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther. 2002;16(2):197-205
• US FDA. Oral health care drug products for over-the-counter human use; tentative final monograph. 21 CFR Part 346
• National Center for Complementary and Integrative Health (NCCIH). Slippery Elm fact sheet
• Drugs.com. Slippery Elm Uses, Benefits & Dosage. drugs.com/npp/slippery-elm.html
• WebMD. Slippery Elm: Uses, Side Effects, and More. webmd.com/vitamins/ai/ingredientmono-978/slippery-elm
• Heinrich M, et al. Slippery Elm (Ulmus rubra). In: THR Monograph Series, 2017
• Peterson CT, et al. Therapeutic uses of triphala in ayurvedic medicine. J Altern Complement Med. 2017;23(8):607-614 (comparative reference for demulcent mechanisms)

Connections

• Compare with Marshmallow as the European functional equivalent; both are mucilaginous demulcents used for GI and throat complaints. Marshmallow has an EMA traditional use monograph while slippery elm has FDA OTC recognition — reflecting their respective geographic traditions
• Related to Licorice as a fellow GI-protective herb; licorice acts through different mechanisms (anti-inflammatory, adrenal modulation) but is often combined with slippery elm in traditional formulas for GERD and gastritis
• Compare with Psyllium as a fellow mucilaginous/bulk-forming agent; psyllium is used primarily for lower GI (constipation, IBS-C), while slippery elm is used primarily for upper GI (throat, esophagus, stomach)
• Related to Linseed as another mucilage-containing botanical used for GI protection; linseed (flaxseed) has stronger evidence for constipation but shares the demulcent rationale for upper GI soothing